BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 33353870)

  • 1. Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer.
    Arvendell M; Björnebo L; Eklund M; Giovanni Falagario U; Chandra Engel J; Akre O; Grönberg H; Nordström T; Lantz A
    Eur Urol Open Sci; 2024 Apr; 62():61-67. PubMed ID: 38468863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool.
    Frendl DM; FitzGerald G; Epstein MM; Allison JJ; Sokoloff MH; Ware JE
    PLoS One; 2020; 15(12):e0240039. PubMed ID: 33284845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study.
    Daskivich TJ; Fan KH; Koyama T; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Stanford JL; Stroup AM; Litwin MS; Penson DF
    Urology; 2015 Jan; 85(1):92-100. PubMed ID: 25261048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.
    Jasu J; Tolonen T; Antonarakis ES; Beltran H; Halabi S; Eisenberger MA; Carducci MA; Loriot Y; Van der Eecken K; Lolkema M; Ryan CJ; Taavitsainen S; Gillessen S; Högnäs G; Talvitie T; Taylor RJ; Koskenalho A; Ost P; Murtola TJ; Rinta-Kiikka I; Tammela T; Auvinen A; Kujala P; Smith TJ; Kellokumpu-Lehtinen PL; Isaacs WB; Nykter M; Kesseli J; Bova GS
    Eur Urol Open Sci; 2021 Aug; 30():47-62. PubMed ID: 34337548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of incidental prostate cancer in the United States.
    Scheipner L; Incesu RB; Morra S; Baudo A; Assad A; Jannello LMI; Siech C; de Angelis M; Barletta F; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Tilki D; Longo N; Carmignani L; De Cobelli O; Ahyai S; Karakiewicz PI
    Prostate Cancer Prostatic Dis; 2023 Oct; ():. PubMed ID: 37872250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality Risks Associated with Depression in Men with Prostate Cancer.
    Crump C; Stattin P; Brooks JD; Sundquist J; Sieh W; Sundquist K
    Eur Urol Oncol; 2024 Apr; ():. PubMed ID: 38575410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States.
    Devasia TP; Mariotto AB; Nyame YA; Etzioni R
    Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):659-665. PubMed ID: 36716178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Housekeeping genes in prostate tumorigenesis.
    Byun J; Logothetis CJ; Gorlov IP
    Int J Cancer; 2009 Dec; 125(11):2603-8. PubMed ID: 19551858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data.
    Yamada Y; Naruse K; Nakamura K; Taki T; Tobiume M; Zennami K; Nishikawa G; Itoh Y; Muramatsu Y; Nanaura H; Nishimura M; Takii K; Adham AO; Honda N
    Exp Ther Med; 2010 Jul; 1(4):635-639. PubMed ID: 22993586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis.
    Li H; Hodgson E; Watson L; Shukla A; Nelson JJ
    J Cancer Epidemiol; 2012; 2012():291704. PubMed ID: 22570655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sadeghian M; Asadi M; Rahmani S; Sadeghi N; Hosseini SA; Zare Javid A
    Nutr Cancer; 2021; 73(11-12):2796-2807. PubMed ID: 33355018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective Study.
    Jin S; Wei J; Wang J; Wang B; Wu J; Gan H; Dai B; Qin X; Lin G; Wei Y; Yang C; Shen Y; Zhu Y; Zhu Y; Ye D
    Front Oncol; 2020; 10():527952. PubMed ID: 33364186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?
    Alvisi MF; Dordoni P; Rancati T; Avuzzi B; Nicolai N; Badenchini F; De Luca L; Magnani T; Marenghi C; Menichetti J; Silvia V; Fabiana Z; Roberto S; Riccardo V; Lara B;
    Front Psychol; 2020; 11():576459. PubMed ID: 33363494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "More men die with prostate cancer than because of it" - an old adage that still holds true in the 21st century.
    C J; Y P; Sf B; Rj B
    Cancer Treat Res Commun; 2021; 26():100225. PubMed ID: 33360667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in men diagnosed with prostate cancer in Poland in the years 2000 - 2014 compared to European Countries based on Concord-3.
    Gliniewicz A; Dudek-Godeau D; Bielska-Lasota M
    Rocz Panstw Zakl Hig; 2020; 71(4):445-453. PubMed ID: 33355426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
    Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
    Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis.
    Kumar J; Alam MU; Jazayeri SB; Tanneru K; Bazargani S; Shastri C; Gautam S; Koochekpour S; Shukla S; Bandyk M; Costa J; Balaji KC
    Indian J Urol; 2022; 38(3):220-226. PubMed ID: 35983120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology grade influences competing mortality risks in elderly men with prostate cancer.
    Alam MU; Kumar J; Norez D; Tanneru K; Jazayeri SB; Bazargani S; Costa J; Bandyk M; Ganapathi HP; Koochekpour S; Gautam S; Balaji KC
    Urol Oncol; 2021 Aug; 39(8):493.e1-493.e7. PubMed ID: 33353870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.